Literature DB >> 25519509

Primary hyperoxalurias: diagnosis and treatment.

Efrat Ben-Shalom1, Yaacov Frishberg.   

Abstract

Primary hyperoxalurias (PH) comprise a group of three distinct metabolic diseases caused by derangement of glyoxylate metabolism in the liver. Recent years have seen advances in several aspects of PH research. This paper reviews current knowledge of the genetic and biochemical basis of PH, the specific epidemiology and clinical presentation of each type, and therapeutic approaches in different disease stages. Potential future specific therapies are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25519509     DOI: 10.1007/s00467-014-3030-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  96 in total

1.  Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1.

Authors:  D Nolkemper; M J Kemper; M Burdelski; I Vaismann; X Rogiers; C E Broelsch; R Ganschow; D E Müller-Wiefel
Journal:  Pediatr Transplant       Date:  2000-08

2.  Hypothyroidism in primary hyperoxaluria type 1.

Authors:  Y Frishberg; S Feinstein; C Rinat; A Drukker
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

3.  Oxalosis; possible inborn error of metabolism with nephrolithiasis and nephrocalcinosis due to calcium oxalate as the predominating features.

Authors:  L Y CHOU; W L DONOHUE
Journal:  Pediatrics       Date:  1952-12       Impact factor: 7.124

4.  Intra-familial clinical heterogeneity: absence of genotype-phenotype correlation in primary hyperoxaluria type 1 in Israel.

Authors:  Yaacov Frishberg; Choni Rinat; Adel Shalata; Ihab Khatib; Sofia Feinstein; Rachel Becker-Cohen; Irit Weismann; Ronald J A Wanders; Gill Rumsby; Frank Roels; Hanna Mandel
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

5.  Primary hyperoxaluria--the German experience.

Authors:  Bernd Hoppe; Kay Latta; Christian von Schnakenburg; Markus J Kemper
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

6.  Kidney transplantation in primary oxalosis: data from the EDTA Registry.

Authors:  M Broyer; F P Brunner; H Brynger; S R Dykes; J H Ehrich; W Fassbinder; W Geerlings; G Rizzoni; N H Selwood; G Tufveson
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

7.  L-glyceric aciduria. A new genetic variant of primary hyperoxaluria.

Authors:  H E Williams; L H Smith
Journal:  N Engl J Med       Date:  1968-02-01       Impact factor: 91.245

8.  Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort.

Authors:  S M van der Hoeven; C S van Woerden; J W Groothoff
Journal:  Nephrol Dial Transplant       Date:  2012-07-27       Impact factor: 5.992

9.  Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

Authors:  R W Watts; R Y Calne; R Williams; M A Mansell; N Veall; P Purkiss; K Rolles
Journal:  Q J Med       Date:  1985-10

10.  Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2.

Authors:  GholamHossein Naderi; AmirHossein Latif; Firouzeh Tabassomi; Seyed Taher Esfahani
Journal:  Pediatr Transplant       Date:  2014-03-05
View more
  12 in total

1.  Metabolite diagnosis of primary hyperoxaluria type 3.

Authors:  Lawrence Greed; Frank Willis; Lilian Johnstone; Sharon Teo; Ruth Belostotsky; Yaacov Frishberg; James Pitt
Journal:  Pediatr Nephrol       Date:  2018-04-28       Impact factor: 3.714

Review 2.  Novel therapeutic approaches for the primary hyperoxalurias.

Authors:  Ruth Belostotsky; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2020-11-06       Impact factor: 3.714

3.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

4.  Long-term complications of systemic oxalosis in children-a retrospective single-center cohort study.

Authors:  Efrat Ben-Shalom; Ruth Cytter-Kuint; Choni Rinat; Rachel Becker-Cohen; Shimrit Tzvi-Behr; Jenny Goichberg; Vardit Peles; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2021-03-02       Impact factor: 3.714

5.  Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.

Authors:  Prince Singh; Jason K Viehman; Ramila A Mehta; Andrea G Cogal; Linda Hasadsri; Devin Oglesbee; Julie B Olson; Barbara M Seide; David J Sas; Peter C Harris; John C Lieske; Dawn S Milliner
Journal:  Nephrol Dial Transplant       Date:  2022-04-25       Impact factor: 7.186

6.  Urinary oxalate to creatinine ratios in healthy Turkish schoolchildren.

Authors:  Ismail Dursun; İlknur Çelik; Hakan M Poyrazoglu; Kader Köse; Esen Tanrıkulu; Habibe Sahin; Kenan Yılmaz; Ahmet Öztürk; Sibel Yel; Zübeyde Gündüz; Ruhan Düşünsel
Journal:  Ren Fail       Date:  2016-11-15       Impact factor: 2.606

7.  Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.

Authors:  Rui Zheng; Xiaoliang Fang; Xi Chen; Yunteng Huang; Guofeng Xu; Lei He; Yueyan Li; Xuran Niu; Lei Yang; Liren Wang; Dali Li; Hongquan Geng
Journal:  Clin Transl Med       Date:  2020-12

8.  Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Authors:  Gema Ariceta; Kelly Barrios; Bob D Brown; Bernd Hoppe; Ralf Rosskamp; Craig B Langman
Journal:  Kidney Int Rep       Date:  2021-02-03

9.  Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.

Authors:  Jana Konkoľová; Ján Chandoga; Juraj Kováčik; Marcel Repiský; Veronika Kramarová; Ivana Paučinová; Daniel Böhmer
Journal:  BMC Med Genet       Date:  2017-05-31       Impact factor: 2.103

10.  Calcium oxalate urolithiasis in juvenile dogs.

Authors:  Alexander Saver; Jody P Lulich; Samantha Van Buren; Eva Furrow
Journal:  Vet Rec       Date:  2021-02-10       Impact factor: 2.560

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.